![](/img/cover-not-exists.png)
Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial
Verschueren, Patrick, De Cock, Diederik, Corluy, Luk, Joos, Rik, Langenaken, Christine, Taelman, Veerle, Raeman, Frank, Ravelingien, Isabelle, Vandevyvere, Klaas, Lenaerts, Jan, Geens, Elke, Geusens,Volume:
17
Language:
english
Journal:
Arthritis Research & Therapy
DOI:
10.1186/s13075-015-0611-8
Date:
December, 2015
File:
PDF, 1.11 MB
english, 2015